Zhongnan Medical Journal Press

Home Results

A total of 70 result was found. Results that relate to System

Effect of Shengjiyuhong ointment on coagulation system, EPCs differentiation and Rho kinase activity in rats with thromboangiitis obliterans by inhibiting autophagy

Published on Frontiers in Pharmaceutical Sciences 2024,27(6):919-927.
2334 times 487 times

CHEN Kui MA Liangliang XU Yindong SHI Li

Shengjiyuhong ointment Autophagy Thromboangiitis obliterans Coagulation system EPCs differentiation Rho kinase activity
Details
Definition and literature of evidence-based urology: a systematic review

Published on New Medicine 2024,34(7):725-743.
2029 times 624 times

WANG Yunyun CHEN Zheng ZHONG Quliang HUANG Xing XU Xiaofeng LI Xiaodong ZI Hao JIN Yinghui LI Binghui WENG Hong DONG Zhilong ZENG Xiantao

Evidence-based medicine Evidence-based urology Definition Methodology Systematic review
Details
A systematic review of the CJFH classification of osteonecrosis of the femoral head

Published on New Medicine 2024,34(7):744-755.
1927 times 543 times

LIU Tianyang SUN Wei GAO Fuqiang LI Zirong

Osteonecrosis of the femoral head CJFH classification Biomechanics Evidence-based clinical study Systematic review
Details
The application of the Chinese Drug-Related Problems Classification System in neurology department pharmaceutical care

Published on Frontiers in Pharmaceutical Sciences 2024,27(7):1202-1209.
2186 times 501 times

GUO Hejian CHEN Guoquan ZHU Yalan CHEN Guangming CHEN Hongfang CHEN Gang

Drug-related problems Chinese Drug-Related Problems Classification System Department of neurology Pharmaceutical care Clinical pharmacist
Details
Data-mining of piperacillin-tazobactam related adverse drug event signals based on FAERS

Published on Frontiers in Pharmaceutical Sciences 2024,27(7):1231-1239.
2247 times 498 times

LIU Jinwei DONG Junli SHAO Yu ZHANG Shaohui

Piperacillin tazobactam Adverse drug event FAERS database Signal mining Diseases of blood and lymphatic system Medication safety
Details
Efficacy and safety of dronedarone in preventing early recurrence of atrial fibrillation after ablation: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(8):899-908.
2043 times 523 times

PANG Yingrong LIANG Shuai SUN Xin SA Rina YANG Lili YANG Jiuyu

Dronedarone Atrial fibrillation Ablation Systematic review Meta-analysis
Details
Signal mining of pneumonia-related adverse events caused by endothelin receptor antagonists based on FAERS database

Published on Frontiers in Pharmaceutical Sciences 2024,27(8):1399-1407.
2062 times 393 times

ZHANG Congjin QIAN Qing QIAN Huolian XU Rufu WANG Qiang

Endothelin receptor antagonists FDA adverse event reporting system Reporting odds ratio Comprehensive standard method Signal mining Adverse drug events
Details
Research progress of Zein-based carrier in drug delivery

Published on Frontiers in Pharmaceutical Sciences 2024,27(8):1424-1435.
2933 times 586 times

WU Zhenyao LIU Guijin

Drug delivery system Zein Biocompatibility Modification Preparation process Speed controlled Targeted Visualized delivery
Details
Establishment, optimization and practice of an automatic central nervous system adverse reactions monitoring module based on hospital information system data

Published on Chinese Journal of Pharmacoepidemiology 2024,33(9):971-977.
2815 times 469 times

LI Haiyan GUO Daihong ZHU Man GAO Ao LU Jingchuan FU An LI Chao LI Peng ZHAO Anqi

Central nervous system Adverse drug reaction Imipenem/cilastatin Text classification technology Real world study
Details
Efficacy and safety of camrelizumab combined with apatinib in the treatment of triple-negative breast cancer: a Meta-analysis and systematic review

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1137-1146.
1787 times 410 times

NIU Zhaofeng ZHAI Yanghai GENG Rui

Camrelizumab Apatinib Triple-negative breast cancer Meta-analysis Systematic review
Details
Efficacy and safety of dapagliflozin combined with sacubitril valsartan in the treatment of heart failure after acute myocardial infarction: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2024,33(11):1254-1264.
1468 times 354 times

BI Longfei LIU Yao LIU Bingxia LI Kui

Dapgliflozin Sacubitril valsartan Myocardial infarction Heart failure Meta-analysis Systematic review Randomized controlled trial
Details
Research progress on the therapeutic effect and mechanism of Xiaoxuming decoction on nervous system diseases

Published on Frontiers in Pharmaceutical Sciences 2024,28(3):536-549.
1969 times 258 times

LIU Xuan HOU Huiling SONG Weipeng LI Xiaoming LIU Yang ZHANG Wei ZHANG Xiwu ZHAO Weiming

Xiaoxuming decoction Nervous system disease Stroke Facial nerve paralysis Vertigo Alzheimer's disease Oxidative stress Autophagy Ferroptosis
Details
Literature analysis of adverse reactions to multiple organ injury induced by camrelizumab

Published on Frontiers in Pharmaceutical Sciences 2024,28(4):648-656.
1462 times 172 times

ZHANG Yang SU Wenyang GAO Yue

Camrelizumab Multiple organ injury Adverse reactions Literature system analysis Immunotherapy Programmed death protein 1
Details
Analysis of the adverse events of axitinib in patients with urinary system tumors and other systemic diseases

Published on Frontiers in Pharmaceutical Sciences 2024,28(4):671-678.
1136 times 141 times

LIU Qing SHAO Chen

Axitinib FDA Adverse Event Reporting System Adverse drug events Data mining Proportional imbalance method Urologic tumors
Details
Analysis on application of new anti-tumor drugs for respiratory system in 121 hospitals in China from 2019 to 2022

Published on Chinese Journal of Pharmacoepidemiology 2025,34(1):27-34.
963 times 134 times

XING Yue LIU Tong ZHONG Lu JIN Yao TENG Xue

New anti-tumor drugs for respiratory system Targeted drugs Immunotherapy drugs DDDs DDC Ranking ratio Drug utilization
Details